Filing Details
- Accession Number:
- 0001181431-12-020982
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-02 14:10:00
- Reporting Period:
- 2012-03-30
- Filing Date:
- 2012-04-02
- Accepted Time:
- 2012-04-02 13:10:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213040 | J. Martha Carter | C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Ste 1850 Cambridge MA 02142 | Chief Regulatory Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-30 | 1,000 | $14.03 | 1,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
